Genetic factors influencing a neurobiological substrate for psychiatric disorders.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
29 03 2021
Historique:
received: 29 10 2019
accepted: 20 01 2021
revised: 07 01 2021
entrez: 30 3 2021
pubmed: 31 3 2021
medline: 29 6 2021
Statut: epublish

Résumé

A retrospective meta-analysis of magnetic resonance imaging voxel-based morphometry studies proposed that reduced gray matter volumes in the dorsal anterior cingulate and the left and right anterior insular cortex-areas that constitute hub nodes of the salience network-represent a common substrate for major psychiatric disorders. Here, we investigated the hypothesis that the common substrate serves as an intermediate phenotype to detect genetic risk variants relevant for psychiatric disease. To this end, after a data reduction step, we conducted genome-wide association studies of a combined common substrate measure in four population-based cohorts (n = 2271), followed by meta-analysis and replication in a fifth cohort (n = 865). After correction for covariates, the heritability of the common substrate was estimated at 0.50 (standard error 0.18). The top single-nucleotide polymorphism (SNP) rs17076061 was associated with the common substrate at genome-wide significance and replicated, explaining 1.2% of the common substrate variance. This SNP mapped to a locus on chromosome 5q35.2 harboring genes involved in neuronal development and regeneration. In follow-up analyses, rs17076061 was not robustly associated with psychiatric disease, and no overlap was found between the broader genetic architecture of the common substrate and genetic risk for major depressive disorder, bipolar disorder, or schizophrenia. In conclusion, our study identified that common genetic variation indeed influences the common substrate, but that these variants do not directly translate to increased disease risk. Future studies should investigate gene-by-environment interactions and employ functional imaging to understand how salience network structure translates to psychiatric disorder risk.

Identifiants

pubmed: 33782385
doi: 10.1038/s41398-021-01317-7
pii: 10.1038/s41398-021-01317-7
pmc: PMC8007575
doi:

Types de publication

Journal Article Meta-Analysis Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

192

Subventions

Organisme : Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research)
ID : 01ZX1314A
Organisme : Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research)
ID : 01ZZ1804A
Organisme : Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research)
ID : 01ER1205
Organisme : Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research)
ID : 01ER1506
Organisme : Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research)
ID : 01ZZ9603
Organisme : Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research)
ID : 01ZZ0103
Organisme : Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research)
ID : 01ZZ0403
Organisme : Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research)
ID : 03IS2061A
Organisme : Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research)
ID : 03ZIK012
Organisme : Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research)
ID : 01ZX1314A
Organisme : Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research)
ID : 01ZX1614J
Organisme : EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)
ID : 785907
Organisme : EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)
ID : EU RIA 733161
Organisme : EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)
ID : 785907
Organisme : EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)
ID : 785907
Organisme : EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020)
ID : 826421
Organisme : Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (Swiss National Science Foundation)
ID : 156791
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : FOR2107: NO246/10-1
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : MU1315/8-2
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : DA 1151/5-1
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : DA 1151/5-2
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : KI 588/14-1
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : KI 588/14-2

Références

Hum Brain Mapp. 2017 Sep;38(9):4444-4458
pubmed: 28580697
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
Neuroimage. 2018 May 15;172:450-460
pubmed: 29410079
Biol Psychiatry. 2010 Nov 1;68(9):832-8
pubmed: 20692648
Bioinformatics. 2010 Sep 1;26(17):2190-1
pubmed: 20616382
Mol Psychiatry. 2016 Jun;21(6):806-12
pubmed: 26122586
Nat Genet. 2010 Jul;42(7):565-9
pubmed: 20562875
Nat Rev Neurosci. 2015 Jan;16(1):55-61
pubmed: 25406711
BMC Psychiatry. 2014 Jun 13;14:174
pubmed: 24924233
Hum Brain Mapp. 2012 Oct;33(10):2377-89
pubmed: 21898677
Mol Psychiatry. 2006 May;11(5):471-8
pubmed: 16402134
J Neurochem. 2004 Nov;91(3):716-36
pubmed: 15485501
PLoS Comput Biol. 2015 Apr 17;11(4):e1004219
pubmed: 25885710
Science. 2018 Jun 22;360(6395):
pubmed: 29930110
Sci Adv. 2016 Jun 17;2(6):e1501678
pubmed: 27386562
Lancet Neurol. 2014 Jul;13(7):686-99
pubmed: 24943344
Int J Epidemiol. 2011 Apr;40(2):294-307
pubmed: 20167617
Arch Gen Psychiatry. 2009 Jul;66(7):721-8
pubmed: 19581563
Proc Natl Acad Sci U S A. 2019 Apr 23;116(17):8582-8590
pubmed: 30962366
Arch Gen Psychiatry. 2009 Sep;66(9):966-975
pubmed: 19736353
Nucleic Acids Res. 2016 Jan 4;44(D1):D877-81
pubmed: 26657631
Mol Psychiatry. 2021 Apr;26(4):1286-1298
pubmed: 31712721
Mol Psychiatry. 2003 Feb;8(2):148-55
pubmed: 12610647
Cell. 2019 Dec 12;179(7):1469-1482.e11
pubmed: 31835028
JAMA Psychiatry. 2015 Apr;72(4):305-15
pubmed: 25651064
J Neurosci. 2007 Feb 28;27(9):2349-56
pubmed: 17329432
Nucleic Acids Res. 2010 Sep;38(17):e169
pubmed: 20660011
Brain Struct Funct. 2019 Dec;224(9):3031-3044
pubmed: 31701266
Nat Genet. 2012 Jul 22;44(8):955-9
pubmed: 22820512
Mol Psychiatry. 2017 Jun;22(6):900-909
pubmed: 27137745
Nat Genet. 2015 Mar;47(3):291-5
pubmed: 25642630
Front Aging Neurosci. 2016 Aug 29;8:204
pubmed: 27616991
Psychol Med. 2019 May;49(7):1166-1173
pubmed: 30221610
Nat Genet. 2015 Nov;47(11):1236-41
pubmed: 26414676
Neuron. 2009 Apr 16;62(1):42-52
pubmed: 19376066
Nat Genet. 2018 May;50(5):668-681
pubmed: 29700475
Front Cell Neurosci. 2014 Oct 27;8:328
pubmed: 25386118
Mol Psychiatry. 2016 Apr;21(4):547-53
pubmed: 26033243
Transl Psychiatry. 2017 Aug 15;7(8):e1205
pubmed: 28809859
Nature. 2014 Jul 24;511(7510):421-7
pubmed: 25056061
Nat Rev Neurosci. 2015 Mar;16(3):159-72
pubmed: 25697159
Sci Rep. 2014 Jan 22;4:3807
pubmed: 24448323
Neuroimage Clin. 2017 Jan 16;14:151-155
pubmed: 28180073
Front Aging Neurosci. 2014 Jul 14;6:149
pubmed: 25071558
Peptides. 2010 Nov;31(11):2094-9
pubmed: 20713105
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Nat Genet. 2019 Nov;51(11):1624-1636
pubmed: 31636452
Mult Scler. 2015 Nov;21(13):1632-43
pubmed: 26432853
Mol Cell Biol. 2004 Nov;24(21):9456-69
pubmed: 15485913
Brain Struct Funct. 2014 Mar;219(2):707-18
pubmed: 23455650
J Psychiatr Res. 2009 Jan;43(3):215-29
pubmed: 18586274
Nat Neurosci. 2019 Mar;22(3):343-352
pubmed: 30718901
Nat Genet. 2019 May;51(5):793-803
pubmed: 31043756
Lancet. 2013 Apr 20;381(9875):1371-1379
pubmed: 23453885
Sci Rep. 2017 Feb 10;7:42140
pubmed: 28186152
Transl Psychiatry. 2020 Apr 27;10(1):122
pubmed: 32341335
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Neuroimage. 2007 Oct 15;38(1):95-113
pubmed: 17761438
Cereb Cortex. 2020 Mar 21;30(2):801-811
pubmed: 31402375
PLoS Genet. 2010 Aug 12;6(8):
pubmed: 20714348
Science. 2015 May 8;348(6235):660-5
pubmed: 25954002
Am J Psychiatry. 2018 Jan 1;175(1):15-27
pubmed: 28969442
Netw Neurosci. 2017 Oct 01;1(3):302-323
pubmed: 29855624
Schizophr Bull. 2014 Sep;40(5):1140-53
pubmed: 24126515
Schizophr Bull. 2018 Jun 6;44(4):854-864
pubmed: 29136250
Psychol Med. 2013 Sep;43(9):1825-36
pubmed: 23254143
PLoS Genet. 2016 May 11;12(5):e1006022
pubmed: 27166630
Neurobiol Aging. 2013 Oct;34(10):2239-47
pubmed: 23643484
Mol Psychiatry. 2016 Dec;21(12):1710-1716
pubmed: 26857596
Eur Arch Psychiatry Clin Neurosci. 2019 Dec;269(8):949-962
pubmed: 30267149
Bioinformatics. 2015 Nov 1;31(21):3555-7
pubmed: 26139635
Hum Mol Genet. 2014 Aug 15;23(16):4420-32
pubmed: 24688116
J Hered. 2015 Sep-Oct;106(5):666-71
pubmed: 26268243
Nat Methods. 2013 Jan;10(1):5-6
pubmed: 23269371
Psychol Med. 2020 Apr;50(6):1020-1031
pubmed: 31084657
Biol Psychiatry. 2018 Nov 1;84(9):644-654
pubmed: 29960671
Nat Neurosci. 2016 Mar;19(3):420-431
pubmed: 26854805
Arch Gen Psychiatry. 2007 Mar;64(3):318-26
pubmed: 17339520
Nat Commun. 2017 May 18;8:15353
pubmed: 28516910
Mol Psychiatry. 2020 Oct;25(10):2210-2213
pubmed: 30886336
Mol Psychiatry. 2020 May 18;:
pubmed: 32424236
J Alzheimers Dis. 2017;57(3):825-843
pubmed: 28304293

Auteurs

Till F M Andlauer (TFM)

Max Planck Institute of Psychiatry, Munich, Germany.
Department of Neurology, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany.

Thomas W Mühleisen (TW)

Institute of Neuroscience and Medicine (INM-1, INM-7), Research Centre Jülich, Jülich, Germany.
Cécile and Oskar Vogt Institute of Brain Research, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Department of Biomedicine, University of Basel, Basel, Switzerland.

Felix Hoffstaedter (F)

Institute of Neuroscience and Medicine (INM-1, INM-7), Research Centre Jülich, Jülich, Germany.

Alexander Teumer (A)

Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.

Katharina Wittfeld (K)

German Center for Neurodegenerative Diseases (DZNE), Site Rostock/Greifswald, Greifswald, Germany.
Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.

Anja Teuber (A)

Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.
Institut für Energie- und Umwelttechnik e.V. (IUTA, Institute of Energy and Environmental Technology), Duisburg, Germany.

Céline S Reinbold (CS)

Department of Biomedicine, University of Basel, Basel, Switzerland.
Department of Psychology, Center for Lifespan Changes in Brain and Cognition, University of Oslo, Oslo, Norway.

Dominik Grotegerd (D)

Department of Psychiatry and Psychotherapy, Westfälische Wilhelms-Universität Münster, Münster, Germany.

Robin Bülow (R)

Institute of Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany.

Svenja Caspers (S)

Institute of Neuroscience and Medicine (INM-1, INM-7), Research Centre Jülich, Jülich, Germany.
Institute for Anatomy I, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Udo Dannlowski (U)

Department of Psychiatry and Psychotherapy, Westfälische Wilhelms-Universität Münster, Münster, Germany.

Stefan Herms (S)

Department of Biomedicine, University of Basel, Basel, Switzerland.
Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany.

Per Hoffmann (P)

Institute of Neuroscience and Medicine (INM-1, INM-7), Research Centre Jülich, Jülich, Germany.
Department of Biomedicine, University of Basel, Basel, Switzerland.
Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany.
Institute of Human Genetics, University of Bonn, Bonn, Germany.

Tilo Kircher (T)

Department of Psychiatry and Psychotherapy, Philipps-Universität Marburg, Marburg, Germany.
Center for Mind, Brain and Behavior (CMBB), University of Marburg and Justus Liebig University Giessen, Marburg, Germany.
Marburg University Hospital - UKGM, Marburg, Germany.

Heike Minnerup (H)

Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.

Susanne Moebus (S)

Institute for Medical Informatics, Biometry and Epidemiology, University Hospital Essen, Essen, Germany.

Igor Nenadić (I)

Department of Psychiatry and Psychotherapy, Philipps-Universität Marburg, Marburg, Germany.
Center for Mind, Brain and Behavior (CMBB), University of Marburg and Justus Liebig University Giessen, Marburg, Germany.
Marburg University Hospital - UKGM, Marburg, Germany.

Henning Teismann (H)

Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.

Uwe Völker (U)

Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.

Amit Etkin (A)

Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA, 94304, USA.
Wu Tsai Neurosciences Institute, Stanford University, Stanford, CA, 94304, USA.
Veterans Affairs Palo Alto Healthcare System, and the Sierra Pacific Mental Illness, Research, Education, and Clinical Center (MIRECC), Palo Alto, CA, 94394, USA.

Klaus Berger (K)

Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.

Hans J Grabe (HJ)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.

Markus M Nöthen (MM)

Department of Genomics, Life & Brain Center, University of Bonn, Bonn, Germany.
Institute of Human Genetics, University of Bonn, Bonn, Germany.

Katrin Amunts (K)

Institute of Neuroscience and Medicine (INM-1, INM-7), Research Centre Jülich, Jülich, Germany.
Cécile and Oskar Vogt Institute of Brain Research, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
JARA-Brain, Jülich-Aachen Research Alliance, Jülich, Germany.

Simon B Eickhoff (SB)

Institute of Neuroscience and Medicine (INM-1, INM-7), Research Centre Jülich, Jülich, Germany.
Institute of Systems Neuroscience, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.

Philipp G Sämann (PG)

Max Planck Institute of Psychiatry, Munich, Germany.

Bertram Müller-Myhsok (B)

Max Planck Institute of Psychiatry, Munich, Germany.
Institute of Translational Medicine, University of Liverpool, Liverpool, UK.

Sven Cichon (S)

Institute of Neuroscience and Medicine (INM-1, INM-7), Research Centre Jülich, Jülich, Germany. s.cichon@fz-juelich.de.
Department of Biomedicine, University of Basel, Basel, Switzerland. s.cichon@fz-juelich.de.
Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland. s.cichon@fz-juelich.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH